Search for: "The Aeolus" Results 1 - 7 of 7
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 May 2020, 1:25 pm by Jon Brodkin
Clerici's client, Aeolus Pharmaceuticals, which an IPR [in-process review] had concluded should be allowed to expire without further funding. [read post]
16 Feb 2011, 12:00 pm by Lucas A. Ferrara, Esq.
Aeolus is developing a broad-spectrum antioxidant drug known as AEOL 10150. [read post]
18 Mar 2019, 6:47 am by Staff Attorney
  In addition, Laidlaw was involved in other securities offerings including Aethlon Medical, Actinium, Boston Therapeutics, 5G Investment, Alliaqua, Aspen Group, Brazahav Resources, Fusion Telecoms International, Protea Biosciences Group, Aeolus Pharmaceuticals, Medovex Corp, Relmada Therapeutics, Sevion Therapeutics, Spectrascience, and Spherix. [read post]
3 Feb 2019, 9:46 am by Staff Attorney
  In addition, Laidlaw was involved in other private placement securities offerings including Aethlon Medical, Actinium, Boston Therapeutics, 5G Investment, Alliaqua, Aspen Group, Brazahav Resources, Fusion Telecoms International, Protea Biosciences Group, Aeolus Pharmaceuticals, Medovex Corp, Relmada Therapeutics, Sevion Therapeutics, Spectrascience, and Spherix. [read post]